Why is Novartis stock tumbling today?

Why is Novartis stock tumbling today?

Why is Novartis stock tumbling today?
Following a sharp selloff in recent months, the South Korean memory-chip company says current share prices don’t reflect the business’s “intrinsic value.”
Editorial & Advertiser disclosure Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press…
Gig platforms offer seamless checkout for buyers, but emerging market payouts remain broken for workers. In June 2026, member states from more than 180 countries convened for the International Labour Conference to determine international labor standards for digital platform workers. However, even with those standards set, payments remain a big issue. Imagine a freelance developer in Lagos,…
The proliferation of prediction markets is increasing competition. *Stock prices used were the afternoon prices of Aug. 10, 2026. The video was published on Aug.12, 2026. Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a…
Prior +2.3% HICP +2.8% vs +2.8% y/y expected Prior +2.4% Core CPI Y/Y +2.4% vs +2.5% prior The inflation rate in Germany is expected to be +2.8% in July 2026. The inflation rate excluding food and energy is expected to stand at +2.4% in July 2026. Energy prices are expected to be up 8.3% on…
SHANGHAI, July 12, 2026 /PRNewswire/ — Insilico Medicine (“Insilico”, 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited (“CMS”, 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced an additional AI‑empowered drug discovery collaboration targeting a mass-market indication in…